UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

European urology, 2012-12, Vol.62 (6), p.976-983

2012

Volltextzugriff (PDF)

Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance

BJU international, 2019-11, Vol.124 (5), p.730-737

2019

Volltextzugriff (PDF)

Germline and somatic DNA repair gene alterations in prostate cancer

Cancer, 2020-07, Vol.126 (13), p.2980-2985

2020

Volltextzugriff (PDF)

No improvement noted in overall or cause‐specific survival for men presenting with metastatic prostate cancer over a 20‐year period

Cancer, 2014-03, Vol.120 (6), p.818-823

2014

Volltextzugriff (PDF)

Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy

The Journal of urology, 2022-03, Vol.207 (3), p.541-550

2022

Volltextzugriff (PDF)

Multiparametric MRI: an important tool to improve risk stratification for active surveillance in prostate cancer

BJU international, 2018-11, Vol.122 (5), p.721-722

2018

Volltextzugriff (PDF)

Molecular Characterization of Neuroendocrine-like Bladder Cancer

Clinical cancer research, 2019-07, Vol.25 (13), p.3908-3920

2019

Volltextzugriff (PDF)

Active surveillance for the management of prostate cancer in a contemporary cohort

Cancer, 2008-06, Vol.112 (12), p.2664-2670

2008

Volltextzugriff (PDF)

Nine‐year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer

Cancer, 2018-05, Vol.124 (9), p.1921-1928

2018

Volltextzugriff (PDF)

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

European urology, 2019-09, Vol.76 (3), p.268-272

2019

Volltextzugriff (PDF)

Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006–2018: Effect of race, age and socioeconomic status on treatment disparities

Urologic oncology, 2023-10, Vol.41 (10), p.431-431.e14

2023

Volltextzugriff (PDF)

Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988–2015

European urology focus, 2019-11, Vol.5 (6), p.1014-1021

2019

Volltextzugriff (PDF)

Differences in mutations across tumour sizes in clear-cell renal cell carcinoma

BJU international, 2024-09

2024

Volltextzugriff (PDF)

Active Surveillance for Prostate Cancer Compared With Immediate Treatment: An Economic Analysis

Cancer, 2012-07, Vol.118 (14), p.3512-3518

2012

Volltextzugriff (PDF)

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells

Scientific reports, 2017-09, Vol.7 (1), p.12277-10, Article 12277

2017

Volltextzugriff (PDF)

New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose?

European urology, 2018-11, Vol.74 (5), p.549-550

2018

Volltextzugriff (PDF)

Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer

The Journal of urology, 2009-04, Vol.181 (4), p.1628-1634

2009

Volltextzugriff (PDF)

The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement

Prostate cancer and prostatic diseases, 2023-08

2023

Volltextzugriff (PDF)

Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery

European urology focus, 2024-05, Vol.10 (3), p.448-453

2024

Volltextzugriff (PDF)

A phase 2 clinical trial of everolimus plus bicalutamide for castration‐resistant prostate cancer

Cancer, 2016-06, Vol.122 (12), p.1897-1904

2016

Volltextzugriff (PDF)

Active Surveillance for Early-stage Prostate Cancer : Review of the Current Literature

Cancer, 2008-04, Vol.112 (8), p.1650-1659

2008

Volltextzugriff (PDF)

Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

Cancer, 2018-09, Vol.124 (17), p.3619-3620

2018

Volltextzugriff (PDF)

Liquid biomarkers in active surveillance

World journal of urology, 2022, Vol.40 (1), p.21-26

Dall’Era, Marc

2022

Volltextzugriff (PDF)

The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype

European urology open science (Online), 2023-06, Vol.52, p.137-144

2023

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(217)
Buchkapitel
(1)

Sprache

Englisch
(218)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(93)
Humans
(79)
Male
(68)
Urology & Nephrology
(66)
Urology
(59)
Prostate Cancer
(36)
Middle Aged
(33)
Oncology
(33)
Aged
(27)
Female
(21)
Tumors
(20)
Bladder Cancer
(18)
Active Surveillance
(17)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Nephrology. Urinary Tract Diseases
(17)
Retrospective Studies
(17)
Urinary Bladder Neoplasms - Pathology
(17)
Treatment Outcome
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance

Germline and somatic DNA repair gene alterations in prostate cancer

No improvement noted in overall or cause‐specific survival for men presenting with metastatic prostate cancer over a 20‐year period

Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy

Multiparametric MRI: an important tool to improve risk stratification for active surveillance in prostate cancer

Molecular Characterization of Neuroendocrine-like Bladder Cancer

Active surveillance for the management of prostate cancer in a contemporary cohort

Nine‐year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006–2018: Effect of race, age and socioeconomic status on treatment disparities

Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988–2015

Differences in mutations across tumour sizes in clear-cell renal cell carcinoma

Active Surveillance for Prostate Cancer Compared With Immediate Treatment: An Economic Analysis

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells

New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose?

Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer

The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement

Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery

A phase 2 clinical trial of everolimus plus bicalutamide for castration‐resistant prostate cancer

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer

Active Surveillance for Early-stage Prostate Cancer : Review of the Current Literature

Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

Liquid biomarkers in active surveillance

The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype

Suchergebnisse filtern